Cotización Upstream Bio - UPB

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

22.31

Postura de Compra

22.09

Postura de Venta

22.33

Volume Operado de la Acción

83,927

21.41 Rango del Día 22.325

17.0885 Rango de 52 semanas 29.30

Precio Anterior

21.63

Precio de Apertura

21.41

Hora

22.1

Última hora de negociación

11:14:29

Volumen promedio (3 m)

317,740

Volumen financiero

US$ 1,834,187

Precio Promedio Ponderado

21.8546

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Form 4 - Statement of changes in beneficial ownership of securities

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...

Form 8-K - Current report

Upstream Bio Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	3.62	19.3686463349	18.69	23.79	18	163966	20.6507672	CS
4	-3.69	-14.1923076923	26	29.3	17.0885	234845	22.84548619	CS
12	0.81	3.76744186047	21.5	29.3	17.0885	317740	23.54461109	CS
26	0.81	3.76744186047	21.5	29.3	17.0885	317740	23.54461109	CS
52	0.81	3.76744186047	21.5	29.3	17.0885	317740	23.54461109	CS
156	0.81	3.76744186047	21.5	29.3	17.0885	317740	23.54461109	CS
260	0.81	3.76744186047	21.5	29.3	17.0885	317740	23.54461109	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CTNTCheetah Net Supply Chain Service Inc	US$ 5.3324 (185.16%)	101.43M
ZJKZJK Industrial Company Ltd	US$ 16.30 (157.10%)	15.7M
JANXJanux Therapeutics Inc	US$ 62.84 (56.40%)	4.57M
CRDOCredo Technology Group Holding Ltd	US$ 71.38 (49.33%)	10.43M
CTORCitius Oncology Inc	US$ 1.51 (48.04%)	93.73M
REVBRevelation Biosciences Inc	US$ 0.5507 (-42.03%)	2.95M
OMEXOdyssey Marine Exploration Inc	US$ 0.4865 (-34.72%)	3M
STSSSharps Technology Inc	US$ 2.37 (-29.33%)	181.1k
GELSGelteq Ltd	US$ 2.7229 (-28.73%)	220.19k
SNTISenti Biosciences Inc	US$ 7.14 (-28.60%)	5.53M
GWAVGreenwave Technology Solutions Inc	US$ 0.5317 (45.67%)	303.07M
SMCISuper Micro Computer Inc	US$ 40.8356 (-2.77%)	151.79M
CTNTCheetah Net Supply Chain Service Inc	US$ 5.3324 (185.16%)	102.98M
CHRSCoherus BioSciences Inc	US$ 1.9793 (44.47%)	96.84M
CTORCitius Oncology Inc	US$ 1.51 (48.04%)	93.89M